Price Alert

BioMarin Pharmaceutical I... (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

57.45

-0.09 (-0.16%)

At close: Aug 18, 2025, 3:59 PM

58.20

1.30%

Pre-market: Aug 19, 2025, 07:00 AM EDT

BioMarin Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	426.86M	167.65M	141.56M	-64.08M
Depreciation & Amortization	96.43M	104.39M	101.97M	108.04M
Stock-Based Compensation	201.57M	207.1M	196.31M	197.26M
Other Working Capital	-184.16M	-57.9M	-5.1M	-15.65B
Other Non-Cash Items	8.29M	61.65M	-115.47M	12.89M
Deferred Income Tax	56.1M	-44.98M	-52.09M	-15.61M
Change in Working Capital	-216.4M	-336.54M	-96.38M	66.03M
Operating Cash Flow	572.84M	159.26M	175.9M	304.54M
Capital Expenditures	-97.42M	-107.61M	-131.54M	-119.22M
Cash Acquisitions	n/a	n/a	n/a	-23.65M
Purchase of Investments	-410.25M	-868.5M	-611.81M	-937.14M
Sales Maturities Of Investments	633.02M	864.86M	620M	691.05M
Other Investing Acitivies	-853K	-10.92M	103.33M	22.65M
Investing Cash Flow	136.49M	-111.24M	-20.03M	-366.31M
Debt Repayment	-494.99M	-2.29M	-2.6M	-3.04M
Common Stock Repurchased	n/a	n/a	-54.28M	-45.8M
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-31.46M	-85.79M	-16.05M	2.99M
Financial Cash Flow	-526.45M	-18.73M	-18.65M	-48K
Net Cash Flow	187.72M	30.6M	137.25M	-61.88M
Free Cash Flow	475.42M	51.65M	44.36M	185.31M